Form D · Other Health Care
Coherus BioSciences, Inc.
Redwood City, CA · CIK 0001512762
Offering snapshot reported Dec 13, 2017 · SEC filing
- Reported sold
- $6.81M Offering amount: $6.81M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 13, 2017 | Initial | $6,806,432 | No comparison | 1 | SEC filing |
| Sep 17, 2015 | Initial | $9,999,980 | No comparison | 1 | SEC filing |
| Jun 4, 2014 | Initial | $55,633,048 | No comparison | 35 | SEC filing |
| Jul 24, 2013 | Initial | $28,000,700 | No comparison | 6 | SEC filing |
| Jan 14, 2013 | Initial | $46,271,280 | No comparison | 23 | SEC filing |
| Jan 3, 2012 | Amendment | $12,853,870 | $9,058,911vs Jul 25, 2011 | 15 | SEC filing |
| Jul 25, 2011 | Initial | $3,794,959 | No comparison | 11 | SEC filing |
| Mar 10, 2011 | Initial | $865,666 | No comparison | 11 | SEC filing |
| Feb 23, 2011 | Initial | $239,920 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-300584
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Dec 13, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stuart E. Builder, Ph.D. | Director |
| Graham K. Crooke, M.D. | Director |
| Douglas H. Farrar | Executive |
| Barbara K. Finck, M.D. | Executive |
| Stephen C. Glover | Executive |
| James I. Healy, M.D., Ph.D. | Director |
| Alan C. Herman | Executive |
| Dennis M. Lanfear | Director, Executive |
| V. Bryan Lawlis | Director |
| V. Bryan Lawlis, Ph.D. | Director |
| John Michael Lazarus, M.D. | Director |
| J. Michael Lazarus, M.D. | Director |
| George G. Montgomery | Executive |
| Cristos Richards | Director |
| Christos Richards | Director |
| Ali J. Satvat | Director |
| Mary T. Szela | Director |
| S. Edward Torres | Director |
| August J. Troendle, M.D. | Director |
| Jean Frederic Viret, Ph.D. | Executive |
| Mats Wahlstrom | Director |
| Peter K. Watler, Ph.D. | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Dennis M. Lanfear 333 Twin Dolphin Dr, Suite 600
Redwood City, CA, 94065
Redwood City, CA, 94065